BRCA1 and neoplasm: Given the importance of tumour morphology features to inform treatment choices and to identify BRCA1 mutation carriers [12] or BRCA1 promoter methylation [13], we are now interested in identifying tumour morphology features that predict familial risk of early-onset breast cancer.